Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product

References

1. Ahn JK, Pitluk ZW, Ward DC. 1992; The GC box and TATA transcription control elements in the P38 promoter of the minute virus of mice are necessary and sufficient for transactivation by the non structural protein NS1.. Journal of Virology 66:3776–3783
   [Google Scholar]
2. Berkhout B, Jeang KT. 1992; Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.. Journal of Virology 66:139–149
   [Google Scholar]
3. Berkhout B, Gatignol A, Rabson AB, Jeang KT. 1990; TAR-independent activation of the F1IV-1 LTR: evidence that Tat requires specific regions of the promoter.. Cell 62:757–767
   [Google Scholar]
4. Bowman CA, Cohen BJ, Norfolk DR, Lacey CJN. 1990; Red cell aplasia associated with human parvovirus B19 and HIV infection: failure to respond clinically to intravenous immunoglobulin.. AIDS 4:1038–1039
   [Google Scholar]
5. Chrystie IL, Almeida JD, Welch J. 1990; Case report: electron microscopic detection of human parvovirus (B19) in a patient with HIV infection.. Journal of Medical Virology 30:249–252
   [Google Scholar]
6. Cullen BR. 1990; The HIV-1 tat protein: an RNA sequence-specific processivity factor. Cell 63:655–657
   [Google Scholar]
7. Cullen BR, Greene WC. 1989; Regulatory pathways governing HIV-1 replication.. Cell 58:423–A26
   [Google Scholar]
8. Davis MG, Kenney SC, Kamine J, Pagano JS, Huang E. 1987; Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.. Proceedings of the National Academy of Sciences, U.S.A. 84:8642–8646
   [Google Scholar]
9. Doerig C, Hirt B, Antonietti JP, Beard P. 1990; Non structural protein of parvovirus B19 and minute virus of mice controls transcription.. Journal of Virology 64:387–396
   [Google Scholar]
10. Frankel AD. 1992; Activation of HIV transcription by Tat.. Current Opinion in Genetics and Development 2:293–298
    [Google Scholar]
11. Frickhofen N, Abkowitz JL, Safford M, Berry M, Antunez-de-Mayolo J, Astrow A, Cohen R, Halperin I, King L, Mintzer D, Cohen B, Young NS. 1990; Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1) : a treatable cause of anemia in AIDS.. Annals of Internal Medicine 113:926–933
    [Google Scholar]
12. Gendelman HE, Phels W, Feigenbaum L, Ostrove JM, Adachi A, Howley PM, Khoury G, Ginsberg HS, Martin MA. 1986; Transactivation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.. Proceedings of the National Academy of Sciences, U.S.A 83:9759–9763
    [Google Scholar]
13. Gorman C, Moffat L, Howard BH. 1982; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.. Molecular and Cellular Biology 2:1044–1051
    [Google Scholar]
14. Kamine J, Chinnadurai G. 1992; Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Spl.. Journal of Virology 66:3932–3936
    [Google Scholar]
15. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. 1989; Immune response to B19 parvovirus and an antibody defect in persistent viral infection.. Journal of Clinical Investigation 84:1114–1123
    [Google Scholar]
16. Laspia MF, Rice AP, Mathews MB. 1990; Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.. Genes and Development 4:2397–2408
    [Google Scholar]
17. Laurence J. 1990; Molecular interactions among herpesviruses and human immunodeficiency viruses. . Journal of Infectious Diseases 162:338–346
    [Google Scholar]
18. Legendre D, Rommelaere J. 1992; Terminal regions of the NS1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter tram-inhibition.. Journal of Virology 66:5705–5713
    [Google Scholar]
19. Liu J, Perkins ND, Schmid RM, Nabel GJ. 1992; Specific NFkB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription.. Journal of Virology 66:3883–3887
    [Google Scholar]
20. Meltzer MS, Skillman DR, Hoover DL, Hanson BD, Turpin JA, Kalter DC, Gendelman HE. 1990; Macrophages and the immunodeficiency virus.. Immunology Today 11:217–223
    [Google Scholar]
21. Mitchell SA, Welch JM, Weston-Smith S, Nicholson F, Bradbeer CS. 1990; Parvovirus infection and anemia in a patient with AIDS: case report.. Genitourinary Medicine 66:95–96
    [Google Scholar]
22. Morey AL, Patou G, Myint S, Fleming KA. 1992; In vitro culture for the detection of infectious human parvovirus B19 and B19-specific antibodies using foetal haematopoietic precursor cells.. Journal of General Virology 73:3313–3317
    [Google Scholar]
23. Nigno G, Luzi G, Fridell E, Ferraza M, Pisano P, Castelli Gattinaraza G, Mezzaroma I, Soderlund M, Rasnoveanu D, Aiuti F. 1992; Parvovirus infection in children with AIDS: high prevalence of B19 specific immunoglobulin M and G antibodies.. AIDS 6:679–684
    [Google Scholar]
24. Ozawa K, Ayub J, Yu-Shu H, Kurtzman G, Shimada T, Young N. 1987; Novel transcription map for the B19 (human) pathogenic parvovirus.. Journal of Virology 61:2395–2406
    [Google Scholar]
25. Porter HJ, Quantrill AM, Fleming KA. 1988; B19 parvovirus infection of myocardial cells.. Lancet i 535–536
    [Google Scholar]
26. Ptashne M. 1988; How eukaryotic transcriptional activators work.. Nature, London 335:683–689
    [Google Scholar]
27. Schwartz O, Virelizier JL, Montagnier L, Hazan U. 1990; A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity.. Gene 88:197–205
    [Google Scholar]
28. Srivastava A, Bruno E, Briddell R, Cooper R, Srivastava C, van Besien K, Hoffman R. 1990; Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro.. Blood 76:1997–2004
    [Google Scholar]
29. Sundstrom C, Nilsson K. 1976; Establishment and characterization of a human histiocytic lymphoma cell line (U-937).. International Journal of Cancer 17:565–577
    [Google Scholar]
30. Wang Y, Larsen AS, Peterlin BM. 1987; A tissue-specific transcriptional enhancer is found in the body of the HLA-DRa gene.. Journal of Experimental Medicine 166:625–637
    [Google Scholar]
31. Webster A, Lee CA, Cook DG, Grundy JE, Emery VC, Kernoff PBA, Griffiths PD. 1989; Cytomegalovirus infection and progression towards AIDS in hemophiliacs with human immunodeficiency virus.. Lancet ii 63–65
    [Google Scholar]
32. Young NS, Mortimer PP, Moore JG, Humphries RK. 1984; Characterization of a virus that causes transient aplastic crisis.. Journal of Clinical Investigation 73:224–230
    [Google Scholar]
33. Zucker-Franklin D, Cao Y. 1989; Megakaryocytes of human immunodeficiency virus infected individuals express viral RNA.. Proceedings of the National Academy of Sciences, U.S.A 86:5595–5599
    [Google Scholar]